Projects

HDR-Brachytherapy as Boost with External Beam Radiotherapy:

      We are collecting 5 years of data on HDR-Brachytherapy for prostate cancer as a boost with external beam radiotherapy to see the local tumor control, overall survival, and toxicity of the treatment

LDR BT TURP study: 

Was a prospective study to evaluate urinary function in patients undergoing LDR brachytherapy for prostate cancer who had undergone a previous TURP which has been completed and is now being prepared for publication. 

Salvage brachytherapy: 

Is increasingly being offered across Europe. UROGEC plans a prospective database to collect a large multicentre series of patients to provide robust data on efficacy and aid guidelines for patient selection. 

Urinary toxicity: 

It is relatively common, and current guidelines focus on urethral constraints as a planning objective to minimize urinary toxicity. We are seeking to explore other constraints which may have more relevance to bladder function for example trigone dose to help define new tolerance doses for these regions.